CN116179375A - High-yield epsilon-polylysine and streptomyces hydrochloride genetically engineered bacterium as well as construction method and application thereof - Google Patents
High-yield epsilon-polylysine and streptomyces hydrochloride genetically engineered bacterium as well as construction method and application thereof Download PDFInfo
- Publication number
- CN116179375A CN116179375A CN202310029098.2A CN202310029098A CN116179375A CN 116179375 A CN116179375 A CN 116179375A CN 202310029098 A CN202310029098 A CN 202310029098A CN 116179375 A CN116179375 A CN 116179375A
- Authority
- CN
- China
- Prior art keywords
- dape
- streptomyces
- gene
- polylysine
- epsilon
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010039918 Polylysine Proteins 0.000 title claims abstract description 58
- 241000187747 Streptomyces Species 0.000 title claims abstract description 45
- 241000894006 Bacteria Species 0.000 title claims abstract description 29
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims abstract description 25
- 238000010276 construction Methods 0.000 title claims description 30
- 101150000582 dapE gene Proteins 0.000 claims abstract description 97
- 238000000855 fermentation Methods 0.000 claims abstract description 62
- 230000004151 fermentation Effects 0.000 claims abstract description 62
- 239000002773 nucleotide Substances 0.000 claims abstract description 27
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 27
- VBNGJYNPUFWTKX-UHFFFAOYSA-N 10,10-diamino-1,6-dioxacyclotridecane-2,5,7,13-tetrone Chemical compound NC1(CCC(=O)OC(CCC(=O)OC(CC1)=O)=O)N VBNGJYNPUFWTKX-UHFFFAOYSA-N 0.000 claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 claims abstract description 20
- 241000142915 Streptomyces diastatochromogenes Species 0.000 claims abstract description 18
- GMKMEZVLHJARHF-UHFFFAOYSA-N 2,6-diaminopimelic acid Chemical compound OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000013612 plasmid Substances 0.000 claims description 80
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 43
- 239000008103 glucose Substances 0.000 claims description 43
- 108090000623 proteins and genes Proteins 0.000 claims description 43
- 241000588724 Escherichia coli Species 0.000 claims description 37
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 34
- 239000001963 growth medium Substances 0.000 claims description 32
- 239000002609 medium Substances 0.000 claims description 28
- 238000000034 method Methods 0.000 claims description 21
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 claims description 20
- 229950006334 apramycin Drugs 0.000 claims description 20
- XZNUGFQTQHRASN-XQENGBIVSA-N apramycin Chemical compound O([C@H]1O[C@@H]2[C@H](O)[C@@H]([C@H](O[C@H]2C[C@H]1N)O[C@@H]1[C@@H]([C@@H](O)[C@H](N)[C@@H](CO)O1)O)NC)[C@@H]1[C@@H](N)C[C@@H](N)[C@H](O)[C@H]1O XZNUGFQTQHRASN-XQENGBIVSA-N 0.000 claims description 20
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 238000012258 culturing Methods 0.000 claims description 18
- 239000007788 liquid Substances 0.000 claims description 16
- 238000001976 enzyme digestion Methods 0.000 claims description 15
- 230000001580 bacterial effect Effects 0.000 claims description 14
- 238000011144 upstream manufacturing Methods 0.000 claims description 13
- 239000004382 Amylase Substances 0.000 claims description 12
- 102000013142 Amylases Human genes 0.000 claims description 12
- 108010065511 Amylases Proteins 0.000 claims description 12
- 235000019418 amylase Nutrition 0.000 claims description 12
- 239000003242 anti bacterial agent Substances 0.000 claims description 12
- 229940088710 antibiotic agent Drugs 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 12
- 239000000843 powder Substances 0.000 claims description 12
- 229930027917 kanamycin Natural products 0.000 claims description 11
- 229960000318 kanamycin Drugs 0.000 claims description 11
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 claims description 11
- 229930182823 kanamycin A Natural products 0.000 claims description 11
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 10
- 229960003276 erythromycin Drugs 0.000 claims description 10
- 239000001301 oxygen Substances 0.000 claims description 10
- 229910052760 oxygen Inorganic materials 0.000 claims description 10
- 239000000047 product Substances 0.000 claims description 10
- 239000011248 coating agent Substances 0.000 claims description 9
- 238000000576 coating method Methods 0.000 claims description 9
- 239000000725 suspension Substances 0.000 claims description 9
- 230000002194 synthesizing effect Effects 0.000 claims description 9
- 230000009286 beneficial effect Effects 0.000 claims description 8
- 239000012634 fragment Substances 0.000 claims description 8
- 239000000243 solution Substances 0.000 claims description 8
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 claims description 7
- 241001467544 Streptomyces galilaeus Species 0.000 claims description 7
- 235000011114 ammonium hydroxide Nutrition 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 7
- 229920001817 Agar Polymers 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 6
- 241000620209 Escherichia coli DH5[alpha] Species 0.000 claims description 6
- 244000068988 Glycine max Species 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 239000012880 LB liquid culture medium Substances 0.000 claims description 6
- 241001052560 Thallis Species 0.000 claims description 6
- 239000008272 agar Substances 0.000 claims description 6
- 229960005091 chloramphenicol Drugs 0.000 claims description 6
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 6
- 238000005520 cutting process Methods 0.000 claims description 6
- 238000005516 engineering process Methods 0.000 claims description 6
- 238000001914 filtration Methods 0.000 claims description 6
- 230000002018 overexpression Effects 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 238000012216 screening Methods 0.000 claims description 6
- 230000035939 shock Effects 0.000 claims description 6
- 239000013589 supplement Substances 0.000 claims description 6
- WIIZWVCIJKGZOK-IUCAKERBSA-N 2,2-dichloro-n-[(1s,2s)-1,3-dihydroxy-1-(4-nitrophenyl)propan-2-yl]acetamide Chemical compound ClC(Cl)C(=O)N[C@@H](CO)[C@@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-IUCAKERBSA-N 0.000 claims description 5
- JOCBASBOOFNAJA-UHFFFAOYSA-N N-tris(hydroxymethyl)methyl-2-aminoethanesulfonic acid Chemical compound OCC(CO)(CO)NCCS(O)(=O)=O JOCBASBOOFNAJA-UHFFFAOYSA-N 0.000 claims description 5
- 239000007994 TES buffer Substances 0.000 claims description 5
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 claims description 5
- 229910052921 ammonium sulfate Inorganic materials 0.000 claims description 5
- 235000011130 ammonium sulphate Nutrition 0.000 claims description 5
- 239000011324 bead Substances 0.000 claims description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 5
- 230000003115 biocidal effect Effects 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 239000012452 mother liquor Substances 0.000 claims description 5
- 229960000210 nalidixic acid Drugs 0.000 claims description 5
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 claims description 5
- 230000035755 proliferation Effects 0.000 claims description 5
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 239000008223 sterile water Substances 0.000 claims description 5
- 238000003756 stirring Methods 0.000 claims description 5
- 238000009423 ventilation Methods 0.000 claims description 5
- 241000588722 Escherichia Species 0.000 claims description 4
- 150000001413 amino acids Chemical class 0.000 claims description 4
- 108091008146 restriction endonucleases Proteins 0.000 claims description 4
- 230000001131 transforming effect Effects 0.000 claims description 4
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 3
- 229930195725 Mannitol Natural products 0.000 claims description 3
- 239000001888 Peptone Substances 0.000 claims description 3
- 108010080698 Peptones Proteins 0.000 claims description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 3
- 235000015278 beef Nutrition 0.000 claims description 3
- 238000009835 boiling Methods 0.000 claims description 3
- 229940041514 candida albicans extract Drugs 0.000 claims description 3
- 238000001816 cooling Methods 0.000 claims description 3
- 239000008367 deionised water Substances 0.000 claims description 3
- 229910021641 deionized water Inorganic materials 0.000 claims description 3
- 239000013613 expression plasmid Substances 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 3
- 239000000594 mannitol Substances 0.000 claims description 3
- 235000010355 mannitol Nutrition 0.000 claims description 3
- 239000013028 medium composition Substances 0.000 claims description 3
- 230000002906 microbiologic effect Effects 0.000 claims description 3
- 238000009629 microbiological culture Methods 0.000 claims description 3
- 235000019319 peptone Nutrition 0.000 claims description 3
- 238000007790 scraping Methods 0.000 claims description 3
- 238000011218 seed culture Methods 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 239000008399 tap water Substances 0.000 claims description 3
- 235000020679 tap water Nutrition 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- 239000012138 yeast extract Substances 0.000 claims description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims 2
- 229910021529 ammonia Inorganic materials 0.000 claims 1
- 239000011550 stock solution Substances 0.000 claims 1
- 239000000758 substrate Substances 0.000 claims 1
- 241000594011 Leuciscus leuciscus Species 0.000 abstract 1
- 229920002472 Starch Polymers 0.000 abstract 1
- 235000019698 starch Nutrition 0.000 abstract 1
- 239000008107 starch Substances 0.000 abstract 1
- 238000003752 polymerase chain reaction Methods 0.000 description 17
- 101000702488 Rattus norvegicus High affinity cationic amino acid transporter 1 Proteins 0.000 description 13
- 238000006243 chemical reaction Methods 0.000 description 11
- 241001655322 Streptomycetales Species 0.000 description 8
- 238000010353 genetic engineering Methods 0.000 description 8
- 238000012795 verification Methods 0.000 description 8
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- 238000003776 cleavage reaction Methods 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 230000007017 scission Effects 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 4
- 230000006801 homologous recombination Effects 0.000 description 4
- 238000002744 homologous recombination Methods 0.000 description 4
- 239000003550 marker Substances 0.000 description 4
- 229920001351 ε-poly-L-lysine Polymers 0.000 description 4
- 241000972623 Streptomyces albulus Species 0.000 description 3
- 241000187759 Streptomyces albus Species 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 230000002779 inactivation Effects 0.000 description 3
- 230000037361 pathway Effects 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229920000742 Cotton Polymers 0.000 description 2
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 2
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 2
- 238000000137 annealing Methods 0.000 description 2
- 238000009395 breeding Methods 0.000 description 2
- 230000001488 breeding effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 238000004925 denaturation Methods 0.000 description 2
- 230000036425 denaturation Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000004907 flux Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000003120 macrolide antibiotic agent Substances 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- -1 polyene compound Chemical class 0.000 description 2
- 150000004291 polyenes Chemical class 0.000 description 2
- 238000012257 pre-denaturation Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000008707 rearrangement Effects 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 230000008719 thickening Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- DVWJFTGEISXVSH-CWVFEVJCSA-N (1R,3S,5S,7Z,11R,12S,13Z,15Z,17Z,19Z,21R,23S,24R,25S)-21-[(2R,3S,4S,5S,6R)-4-amino-3,5-dihydroxy-6-methyloxan-2-yl]oxy-12-ethyl-1,3,5,25-tetrahydroxy-11-methyl-9-oxo-10,27-dioxabicyclo[21.3.1]heptacosa-7,13,15,17,19-pentaene-24-carboxylic acid Chemical compound CC[C@H]1\C=C/C=C\C=C/C=C\[C@@H](C[C@@H]2O[C@@](O)(C[C@H](O)[C@H]2C(O)=O)C[C@@H](O)C[C@@H](O)C\C=C/C(=O)O[C@@H]1C)O[C@@H]1O[C@H](C)[C@@H](O)[C@H](N)[C@@H]1O DVWJFTGEISXVSH-CWVFEVJCSA-N 0.000 description 1
- 108050001492 Ammonium transporters Proteins 0.000 description 1
- 101100323184 Aquifex aeolicus (strain VF5) amt gene Proteins 0.000 description 1
- 101100162669 Bacillus subtilis (strain 168) nrgA gene Proteins 0.000 description 1
- 102000000634 Cytochrome c oxidase subunit IV Human genes 0.000 description 1
- 108090000365 Cytochrome-c oxidases Proteins 0.000 description 1
- 101100024093 Danio rerio paqr7b gene Proteins 0.000 description 1
- 108050000784 Ferritin Proteins 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 101100350989 Mus musculus Paqr7 gene Proteins 0.000 description 1
- 240000000513 Santalum album Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 101150001904 amtB gene Proteins 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000010367 cloning Methods 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 238000005536 corrosion prevention Methods 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 238000012262 fermentative production Methods 0.000 description 1
- 108010014388 ferritin reductase Proteins 0.000 description 1
- 238000009920 food preservation Methods 0.000 description 1
- 108091008053 gene clusters Proteins 0.000 description 1
- 238000003208 gene overexpression Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 229920000656 polylysine Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 229930000044 secondary metabolite Natural products 0.000 description 1
- 230000019491 signal transduction Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229930183279 tetramycin Natural products 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/80—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in linear amides (3.5.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/465—Streptomyces
- C12R2001/525—Streptomyces diastatochromogenes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The invention discloses a high-yield epsilon-polylysine and Streptomyces hydrochlorus genetically engineered bacterium, which is obtained by over-expressing succinyldiaminopimelate dissuccinylase gene dapE in diaminopimelate DAP in S.diastatocochromagenes 6# -7, wherein the nucleotide sequence of the over-expressed dapE gene has 83.9% or more of consistency with SEQ ID No. 1. The invention takes streptomyces diastatochromogenes6# -7 as chassis strain, and over-expresses the gene dapE of the starch succinyl diaminopimelate dissuccinylase to obtain the high-yield engineering strain dacE of streptomyces diastatochromogenes of the over-expressed dapE gene. The fermentation level of epsilon-polylysine can be obviously improved, the production strength of the strain can be improved, and the production cost can be reduced by using the high-yield engineering strain streptomyces diastatochromogenes dapE for fermentation production of epsilon-polylysine and hydrochloride thereof.
Description
Technical Field
The invention belongs to the technical field of bioengineering, relates to a construction method and application of a genetic engineering strain, and in particular relates to a genetic engineering strain for high-yield epsilon-polylysine and streptomyces hydrochloride thereof, and a construction method and application of the genetic engineering strain.
Background
Epsilon-polylysine (epsilon-Poly-L-lysine, epsilon-PL) is prepared from 25-35L-lysine monomers by reacting alpha-COOH and epsilon-NH 2 A natural amino acid homopolymer obtained by dehydration condensation. The epsilon-polylysine and the hydrochloride thereof have the advantages of wide antibacterial spectrum, good thermal stability and water solubility, safety and innocuity to human bodies, and have development potential in the fields of food preservation and corrosion prevention, and can be used as drug coating, cosmetics, drug carriers and the like.
In order to improve the yield of epsilon-polylysine and reduce the production cost, the prior related research is mostly started from the aspects of fermentation process optimization, mutation breeding and the like. However, there are relatively few reports and studies on the construction of engineering strains with high epsilon-polylysine yield, particularly on the method of overexpressing succinyldiaminopimelate disuccinidase (dapE) in the diaminopimelate pathway (DAP).
By searching, the following publications related to the present patent application are found:
1. a Streptomyces albus gene engineering bacterium, its construction method and application (CN 105441373A, 2015.12.4) discloses a Streptomyces albus PD-4, which is prepared by over-expressing an ammonium transporter gene amtB from S.albus PD-1 genome and improving epsilon-polylysine fermentation level by improving nitrogen source supply.
2. Streptomyces and a method for preparing epsilon-polylysine by the same (CN 110804572A, 2019.12.4) are disclosed, and a Streptomyces and a method for preparing epsilon-polylysine by the same are disclosed, belonging to the field of microbial fermentation. The genome rearrangement strain is produced by carrying out resistance screening on concentration gradient on S.album M-Z18, the yield of fermentation for 192 hours can reach 56.3g/L, but the genome rearrangement method for breeding high-yield strains has the defects of large workload and strong uncertainty.
3. Mao Zhonggui et al (Understanding high ε -poly-l-lysine production by Streptomyces albulus using pH shock strategy in the level of transgenics. Journal of Industrial Microbiology & Biotechnology,2019, 46:1781-1792.) in the literature, employ a pH impact strategy to activate the MprA/B and PepD signal transduction systems of S.albulus M-Z18, forward regulate transcription of ε -polylysine synthase (Pls) genes, increasing the activity of Pls during fermentation; meanwhile, the strategy also promotes the transcription of cytochrome c oxidase, ferritin reductase and ferritin gene, improves the respiratory activity of cells and increases the yield of epsilon-polylysine.
4. In Yamanaka et al (Enhancement ofmetabolic flux toward epsilon-poly-l-lysine biosynthesis by targeted inactivation of concomitant polyene macrolide biosynthesis in Streptomyces albulus Enhancement of metabolic flux toward epsilon-poly-l-lysine biosynthesis by targeted inactivation of concomitant polyene macrolide biosynthesis in Streptomyces album. Journal ofBioscience and Bioengineering,2020,129 (5): 558-564.) the epsilon-polylysine yield was increased by 20% over the starting strain by targeted inactivation of large gene fragments in the possible tetramycin and tetracycline biosynthesis (TTM) gene cluster, while the polyene compound yield in the secondary metabolite was reduced to 0.
By contrast, the present patent application differs essentially from the above-mentioned patent publications in terms of chassis strains and construction strategies.
Disclosure of Invention
The invention aims to overcome the problems in the prior art and provides a genetically engineered bacterium for high-yield epsilon-polylysine and streptomyces hydrochloride thereof, and a construction method and application thereof.
The technical scheme adopted for solving the technical problems is as follows:
a high-yield epsilon-polylysine and its hydrochloride streptomycete genetic engineering bacteria, the engineering bacteria are amylase chromogenic streptomycete dapE (Streptomyces diastatochromogenes dapE), the amylase chromogenic streptomycete dapE is obtained by over-expressing succinyl diaminopimelate dissuccinylase gene dapE in S.diastatocochrome 6, the nucleotide sequence of the over-expressed dapE gene has 83.9% or more of the identity with SEQ ID No. 1.
Further, the deposit number of s.diastatocochromenes 6# -7 is: CGMCC No.22261, preservation date: 2021, 4 months 30, address: beijing, chaoyang area, north Chen Xi Lu 1, 3, china academy of sciences microbiological institute, deposit unit: china general microbiological culture Collection center (China Committee for culture Collection).
The construction method of the genetically engineered bacteria for producing epsilon-polylysine and streptomyces hydrochloride with high yield comprises the following steps:
(1) Over-expression gene dapE, wherein the nucleotide sequence of the gene dapE has 83.9% and above consistency with SEQ ID No. 1;
(2) Amplifying or directly synthesizing the dapE gene by a PCR technology;
(3) The over-expression plasmid used in the construction was plasmid pIMEP with the strong promoter erythromycin promoter ermE.
Further, the steps are as follows:
(1) Extracting genome of S.diastatocochromenes 6# -7, using the genome as a template, and amplifying a target gene by adopting a PCR technology, wherein the target gene is succinyldiaminopimelate dissuccinylase gene dapE; or directly synthesizing the dapE nucleotide sequence with the same function of other streptomyces obtained according to NCBI retrieval;
(2) Inserting the target gene dapE obtained in the step (1) between enzyme cutting sites of a plasmid pIMEP integrated with a strong promoter erythromycin promoter ermE to obtain a recombinant plasmid pIMEP carrying the target gene, converting the recombinant plasmid pIMEP into escherichia coli DH5 alpha, and screening to obtain escherichia coli DH5 alpha positive transformants;
(3) Extracting recombinant plasmid pIMEP in E.coli DH5 alpha positive transformant of step (2), namely dapE, firstly transforming the extracted recombinant plasmid pIMEP into E.coli ET12567 (pUZ 8002), coating on LB plate containing 20-25 ng/. Mu.L kanamycin, 30-50 ng/. Mu.L apramycin and 20-25 ng/. Mu.L chloramphenicol, selecting E.coli ET12567 (pUZ 8002) positive transformant, culturing in LB liquid culture medium containing same concentration of three antibiotics of kanamycin, apramycin and chloramphenicol at constant temperature of 37-40 deg.C overnight, transferring into LB liquid culture medium containing same concentration of kanamycin, apramycin and chloramphenicol antibiotic, culturing at 180r/min at 37-40 deg.C until OD 600 Between 0.4 and 0.6, centrifugally collecting bacterial liquid, washing bacterial cells with fresh LB for 2-3 times to remove residual antibiotics, and re-suspending the bacterial cells in LB liquid medium to be placed on ice for standby, so as to obtain treated escherichia coli ET12567 (pUZ 8002) positive transformant cells;
(4) Adding TES buffer solution with pH=8.0 to the plate of S.diastatocochromenes 6# -7 strain producing spore on bennett culture medium, scraping S.diastatocochromenes 6# -7 spore, pouring into a container containing glass beads, breaking spore chain by 180r/min oscillation, filtering to remove mycelium, collecting spore suspension, cooling spore suspension to room temperature after water bath heat shock, adding M3G culture medium, shake culturing at 37-40deg.C for 2-3 hr to germinate spores, centrifuging at 5000r/min for 5min to collect S.diastatocochromenes 6# -7 germinated spores, and re-suspending for use;
(5) Mixing positive transformant E.coli ET12567 (pUZ 8002) of step (3) and S.diastatocochromenes 6# -7 germinated spores of step (4) in equal volume, uniformly coating on a medium containing 5-8mM Mg 2+ After the SFM culture medium is subjected to inversion culture for 14-18h at 30 ℃, the flat plate is covered by sterile water containing nalidixic acid with the concentration of 20-25mg/mL and apramycin with the concentration of 20-25mg/mL, the flat plate is dried and then is subjected to inversion culture for 3-5 days, and positive monoclonal zygotes are screened to obtain the high-yield engineering bacteria.
Further, the construction steps of the step (2) carrying the target gene recombinant plasmid pIMEP are as follows:
(a) Obtaining the target fragment gene: designing a primer sequence dapE-F/dapE-R according to a required gene, introducing EcoR I enzyme cutting sites at two ends of the gene, wherein 6 nucleotides are added at the upstream 5 'end and 6 nucleotides are added at the downstream 5' end of the nucleotide sequence to form a restriction enzyme EcoR I site, and amplifying the target gene dapE in the streptomyces diastatochromogenes 6.7 by PCR; or directly synthesizing a Streptomyces galileo (Streptomyces galilaeus) gene dapE with the same function;
the target gene dapE sequence in the amplified amylase streptomyces chromogenes 6-7 is as follows: SEQ ID No.1;
primer dapE-F: SEQ ID No.2;
primer dapE-R: SEQ ID No.3;
the sequence of the Streptomyces galileo (Streptomyces galileus) gene dapE is: SEQ ID No.8;
(b) Construction of recombinant plasmids: the EcoR I single enzyme digestion plasmid pIMEP is used, the amplified target gene fragment is connected with the single enzyme digestion plasmid pIMEP plasmid after the EcoR I single enzyme digestion to obtain a connection product recombinant plasmid, the connection product recombinant plasmid is transformed into E.coli DH5 alpha competent cells, E.coli DH5 alpha positive transformants are selected for preservation, and the target gene carrying recombinant plasmid pIMEP:: dapE is obtained.
Furthermore, the pIMEP plasmid is constructed by connecting erythromycin promoter ermE in front of a polyclonal site on the basis of pSET 152 plasmid, and the plasmid is a shuttle plasmid of escherichia coli-streptomycete, and can be used for expressing genes in streptomycete;
the formula of the culture medium is as follows:
every 1LM3G medium composition was: (NH) 4 ) 2 SO 4 10 g,KH 2 PO 4 1.36 g,K 2 HPO 4 0.8 5g of yeast extract, regulating the pH to 7.2 by ammonia water, adding water to a volume of 900mL, and adding 100mL of 10 Xglucose mother liquor;
every 1L of M3G medium containing glucose, the fermentation medium is short: when using M3G culture medium for fermentation, 100ml10×glucose mother liquor is added per 900ml M3G; 10 x glucose stock: 50g of glucose was weighed and 1ml of 500 XSO was added 4 ·7H 2 O and 1ml of 20 XMgSO 4 ·7H 2 O, sterilizing after the volume is fixed to 100ml by deionized water;
the composition of the bennett culture medium per 1L is: 10g of glucose, 2g of peptone, 1g of yeast powder, 1g of beef extract and 15-20g of agar, adding water to supplement 1L, and adjusting pH to 7.7 with NaOH;
the composition of each 1L of SFM medium was: 30g of soybean cake powder, 20g of mannitol and 15-20g of agar powder, adding water to supplement 1L, and regulating the pH to 7.2-7.4 by NaOH; wherein, the soybean cake powder is used after the following treatment: adding 800-900mL tap water, boiling for 30-60min, and filtering with gauze.
A method for improving the yield of epsilon-polylysine and hydrochloride thereof by using the genetically engineered bacteria comprises the step of improving the fermentation level of epsilon-polylysine through the fermentation of streptomyces diastatochromogenes dapE.
Further, the method comprises the following steps:
the adopted strain is a genetically engineered strain which is used for over-expressing succinyldiaminopimelate dissuccinylase gene dapE, namely amylase streptomyces chromogenes dapE, the genetically engineered strain is inoculated on a bennett culture medium plate and is cultured at 28-35 ℃ until black gray conidia are produced; then inoculating the spores into a shaking bottle of an M3G culture medium containing glucose, culturing for 30-33 hours at 28-35 ℃ and 180rpm/min, transferring the cultured seed culture solution into the M3G culture medium containing glucose for shaking bottle or fermentation tank fed-batch fermentation, and obtaining the epsilon-polylysine-containing fed-batch fermentation amino acid fermentation liquor.
Further, the feed fermentation comprises the following steps:
initial ph=6.8, control in two stages: in the stage I, the pH is controlled at 6.0 so as to be beneficial to the proliferation of thalli; step II, when the glucose concentration in the fermentation liquor is reduced to 10g/L, naturally reducing the pH to 4.0, then automatically feeding ammonia water with the mass concentration of 12.5% to maintain the pH to 4.0, and simultaneously feeding a mixed liquor of glucose and ammonium sulfate to control the glucose concentration to 10g/L; in the fermentation process, the temperature is controlled at 30 ℃, the dissolved oxygen is controlled at 30%, the ventilation ratio is maintained at 1-2vvm, and stirring is associated with the dissolved oxygen until the yield is highest.
The genetically engineered bacterium is applied to epsilon-polylysine and hydrochloride production thereof.
The beneficial effects obtained by the invention are as follows:
1. the invention takes streptomyces diastatochromogenes 6-7 as chassis strain, over-expresses streptomyces diastatochromogenes 6-7 itself or succinyl diaminopimelate disuccinate gene dapE of heterodiaminopimelate pathway (DAP), and obtains high-yield engineering strain streptomyces diastatochromogenes dapE over-expressing dapE gene. The fermentation level of epsilon-polylysine can be obviously improved, the production strength of the strain can be improved, and the production cost can be reduced by using the high-yield engineering strain streptomyces diastatochromogenes dapE for fermentation production of epsilon-polylysine and hydrochloride thereof.
2. The method of the invention obtains the high-yield engineering strain S.diastatocochromenes dapE (comprising dapE-1 and dapE-2) by overexpressing succinyldiaminopimelate dissuccinylase gene dapE of diaminopimelate pathway (DAP). Experiments prove that under the shake flask fermentation condition, the ability of the S.diastachromene-1 strain to produce epsilon-polylysine is improved by 20.1% compared with that of the original strain S.diastachromene 6# -7 under the same condition; under the fed-batch fermentation condition of a 5L fermentation tank, the capacities of the S.diastatocochromene-1 strain and the S.diastatocochromene-2 strain for producing epsilon-polylysine are respectively improved by 22.4 percent and 25.3 percent under the same condition compared with the capacity of the original strain S.diastatocochromene 6# -7, and excellent strains are provided for epsilon-polylysine and hydrochloride production thereof.
3. The method of the invention improves the production strength of the engineering strain S.diastatocochromene dapE (dapE-1 and dapE-2) unit thalli by 31.8 percent and 44.7 percent respectively compared with the original strain S.diastatocochromene 6# -7; wherein, the conversion rate of the engineering strain S.diastatocochromene dapE-2 glucose is improved by 4.2 percent, and the production cost of epsilon-polylysine and hydrochloride thereof is obviously reduced.
Drawings
FIG. 1 is a diagram showing the PCR product of the gene dapE of succinyldiaminopimelate dissuccinylase with homology arms amplified from the genome of the starting strain Sdiastatochromogens 6-7 according to the present invention; wherein lane M: a 5kb marker; lane 1: amplified dapE with homology arm (1089 bp);
FIG. 2 is a schematic diagram showing construction of a recombinant plasmid of dapE, wherein the pIMEP is constructed based on pIMEP;
FIG. 3 is a diagram showing the verification of the digestion of plasmid extraction of recombinant plasmid positive transformants for construction of pIMEP-dapE (wherein dapE is the S. Diastatochromogens gene) according to the present invention; wherein lane M: a 10kb marker; lane 1: ecoRI single enzyme digestion result of pIMEP-dapE recombinant plasmid, the two bands are 6322bp and 1089bp;
FIG. 4 is a diagram showing the verification of successful binding transfer by using the dapE-1 gene and a part of plasmid sequence, wherein the genome of the positive transformant of the genetically engineered strain S.diastatocochromene dapE-1 is obtained in the present invention; wherein lane M:2kb marker; lane 1: verifying the integrated dapE-1 gene in the genetically engineered strain S.diastatocochromene dapE-1; lane 2: control 6# -7 has no corresponding gene;
FIG. 5 is a graph showing the yield of epsilon-polylysine by shake flask fermentation of a strain of the present invention at 96 hours; wherein 6# -7 is the original strain S.diastatocochromogenes 6# -7, and dapE-1 is the high-yield epsilon-polylysine genetic engineering strain S.diastatocochromogenes dapE-1;
FIG. 6 shows the fed-batch fermentation results of a 5L fermenter of the starting strain S.diastatocochromene 6# -7 and the high-yield engineering strain S.diastatocochromene dapE-1 according to the present invention;
FIG. 7 is a diagram showing the verification of the digestion of plasmid extraction of a recombinant plasmid-positive transformant for constructing pIMEP-dapE (wherein dapE is the Streptomyces galilaeus gene) according to the present invention; wherein lane M: a 10kb marker; lane 1: ecoRI single enzyme digestion result of pIMEP-dapE recombinant plasmid, the two bands are 6322bp and 1080bp;
FIG. 8 shows the fed-batch fermentation results of a 5L fermenter containing the starting strain S.diastatocochromene 6# -7 and the high-yield engineering strain S.diastatocochromene dapE-2 according to the present invention.
Detailed Description
The present invention will be further described in detail with reference to examples, but the scope of the present invention is not limited to the examples.
The raw materials used in the invention are conventional commercial products unless otherwise specified, the methods used in the invention are conventional methods in the art unless otherwise specified, and the mass of each substance used in the invention is conventional.
A high-yield epsilon-polylysine and its hydrochloride streptomycete genetic engineering bacteria, the engineering bacteria are amylase chromogenic streptomycete dapE (Streptomyces diastatochromogenes dapE), the amylase chromogenic streptomycete dapE is obtained by over-expressing succinyl diaminopimelate dissuccinylase gene dapE in S.diastatocochrome 6, the nucleotide sequence of the over-expressed dapE gene has 83.9% or more of the identity with SEQ ID No. 1.
Preferably, the deposit number of S.diastatocochromenes 6-7 is: CGMCC No.22261, preservation date: 2021, 4 months 30, address: beijing, chaoyang area, north Chen Xi Lu 1, 3, china academy of sciences microbiological institute, deposit unit: china general microbiological culture Collection center (China Committee for culture Collection).
The construction method of the genetically engineered bacteria for producing epsilon-polylysine and streptomyces hydrochloride with high yield comprises the following steps:
(4) Over-expression gene dapE, wherein the nucleotide sequence of the gene dapE has 83.9% and above consistency with SEQ ID No. 1;
(5) Amplifying or directly synthesizing the dapE gene by a PCR technology;
(6) The over-expression plasmid used in the construction was plasmid pIMEP with the strong promoter erythromycin promoter ermE.
Preferably, the steps are as follows:
(1) Extracting genome of S.diastatocochromenes 6# -7, using the genome as a template, and amplifying a target gene by adopting a PCR technology, wherein the target gene is succinyldiaminopimelate dissuccinylase gene dapE; or directly synthesizing the dapE nucleotide sequence with the same function of other streptomyces obtained according to NCBI retrieval;
(2) Inserting the target gene dapE obtained in the step (1) between enzyme cutting sites of a plasmid pIMEP integrated with a strong promoter erythromycin promoter ermE to obtain a recombinant plasmid pIMEP carrying the target gene, converting the recombinant plasmid pIMEP into escherichia coli DH5 alpha, and screening to obtain escherichia coli DH5 alpha positive transformants;
(3) Extracting recombinant plasmid pIMEP in E.coli DH5 alpha positive transformant of step (2), namely dapE, firstly transforming the extracted recombinant plasmid pIMEP into E.coli ET12567 (pUZ 8002), coating on LB plate containing 20-25 ng/. Mu.L kanamycin, 30-50 ng/. Mu.L apramycin and 20-25 ng/. Mu.L chloramphenicol, selecting E.coli ET12567 (pUZ 8002) positive transformant, culturing in LB liquid culture medium containing same concentration of three antibiotics of kanamycin, apramycin and chloramphenicol at constant temperature of 37-40 deg.C overnight, transferring into LB liquid culture medium containing same concentration of kanamycin, apramycin and chloramphenicol antibiotic, culturing at 180r/min at 37-40 deg.C until OD 600 Between 0.4 and 0.6, centrifugally collecting bacterial liquid, washing bacterial cells with fresh LB for 2-3 times to remove residual antibiotics, and re-suspending the bacterial cells in LB liquid medium to be placed on ice for standby, so as to obtain treated escherichia coli ET12567 (pUZ 8002) positive transformant cells;
(4) Adding TES buffer solution with pH=8.0 to the plate of S.diastatocochromenes 6# -7 strain producing spore on bennett culture medium, scraping S.diastatocochromenes 6# -7 spore, pouring into a container containing glass beads, breaking spore chain by 180r/min oscillation, filtering to remove mycelium, collecting spore suspension, cooling spore suspension to room temperature after water bath heat shock, adding M3G culture medium, shake culturing at 37-40deg.C for 2-3 hr to germinate spores, centrifuging at 5000r/min for 5min to collect S.diastatocochromenes 6# -7 germinated spores, and re-suspending for use;
(5) Mixing positive transformant E.coli ET12567 (pUZ 8002) of step (3) and S.diastatocochromenes 6# -7 germinated spores of step (4) in equal volume, uniformly coating on a medium containing 5-8mM Mg 2+ After the SFM culture medium is subjected to inversion culture for 14 to 18 hours at the temperature of 30 ℃, the flat plate is covered by sterile water containing nalidixic acid with the concentration of 20 to 25mg/mL and apramycin with the concentration of 20 to 25mg/mL, the flat plate is dried and then is subjected to inversion culture for 3 to 5 days, positive monoclonal zygotes are screened, Obtaining the high-yield engineering bacteria.
Preferably, the construction steps of the step (2) carrying the target gene recombinant plasmid pIMEP are as follows:
(a) Obtaining the target fragment gene: designing a primer sequence dapE-F/dapE-R according to a required gene, introducing EcoR I enzyme cutting sites at two ends of the gene, wherein 6 nucleotides are added at the upstream 5 'end and 6 nucleotides are added at the downstream 5' end of the nucleotide sequence to form a restriction enzyme EcoR I site, and amplifying the target gene dapE in the streptomyces diastatochromogenes 6.7 by PCR; or directly synthesizing a Streptomyces galileo (Streptomyces galilaeus) gene dapE with the same function;
the target gene dapE sequence in the amplified amylase streptomyces chromogenes 6-7 is as follows: SEQ ID No.1;
primer dapE-F: SEQ ID No.2;
primer dapE-R: SEQ ID No.3;
the sequence of the Streptomyces galileo (Streptomyces galileus) gene dapE is: SEQ ID No.8;
(b) Construction of recombinant plasmids: the EcoR I single enzyme digestion plasmid pIMEP is used, the amplified target gene fragment is connected with the single enzyme digestion plasmid pIMEP plasmid after the EcoR I single enzyme digestion to obtain a connection product recombinant plasmid, the connection product recombinant plasmid is transformed into E.coli DH5 alpha competent cells, E.coli DH5 alpha positive transformants are selected for preservation, and the target gene carrying recombinant plasmid pIMEP:: dapE is obtained.
Preferably, the pIMEP plasmid is constructed by connecting erythromycin promoter ermE in front of a multiple cloning site on the basis of pSET 152 plasmid, and the plasmid is a shuttle plasmid of escherichia coli-streptomycete, and can be used for expressing genes in streptomycete;
the formula of the culture medium is as follows:
every 1LM3G medium composition was: (NH) 4 ) 2 SO 4 10 g,KH 2 PO 4 1.36 g,K 2 HPO 4 0.8 5g of yeast extract, regulating the pH to 7.2 by ammonia water, adding water to a volume of 900mL, and adding 100mL of 10 Xglucose mother liquor;
every 1L of M3G culture medium containing glucose, short for shortFermentation medium: when using M3G culture medium for fermentation, 100ml10×glucose mother liquor is added per 900ml M3G; 10 x glucose stock: 50g of glucose was weighed and 1ml of 500 XSO was added 4 ·7H 2 O and 1ml of 20 XMgSO 4 ·7H 2 O, sterilizing after the volume is fixed to 100ml by deionized water;
the composition of the bennett culture medium per 1L is: 10g of glucose, 2g of peptone, 1g of yeast powder, 1g of beef extract and 15-20g of agar, adding water to supplement 1L, and adjusting pH to 7.7 with NaOH;
the composition of each 1L of SFM medium was: 30g of soybean cake powder, 20g of mannitol and 15-20g of agar powder, adding water to supplement 1L, and regulating the pH to 7.2-7.4 by NaOH; wherein, the soybean cake powder is used after the following treatment: adding 800-900mL tap water, boiling for 30-60min, and filtering with gauze.
A method for improving the yield of epsilon-polylysine and hydrochloride thereof by using the genetically engineered bacteria comprises the step of improving the fermentation level of epsilon-polylysine through the fermentation of streptomyces diastatochromogenes dapE.
Preferably, the method comprises the steps of:
the adopted strain is a genetically engineered strain which is used for over-expressing succinyldiaminopimelate dissuccinylase gene dapE, namely amylase streptomyces chromogenes dapE, the genetically engineered strain is inoculated on a bennett culture medium plate and is cultured at 28-35 ℃ until black gray conidia are produced; then inoculating the spores into a shaking bottle of an M3G culture medium containing glucose, culturing for 30-33 hours at 28-35 ℃ and 180rpm/min, transferring the cultured seed culture solution into the M3G culture medium containing glucose for shaking bottle or fermentation tank fed-batch fermentation, and obtaining the epsilon-polylysine-containing fed-batch fermentation amino acid fermentation liquor.
Preferably, the feed fermentation comprises the steps of:
initial ph=6.8, control in two stages: in the stage I, the pH is controlled at 6.0 so as to be beneficial to the proliferation of thalli; step II, when the glucose concentration in the fermentation liquor is reduced to 10g/L, naturally reducing the pH to 4.0, then automatically feeding ammonia water with the mass concentration of 12.5% to maintain the pH to 4.0, and simultaneously feeding a mixed liquor of glucose and ammonium sulfate to control the glucose concentration to 10g/L; in the fermentation process, the temperature is controlled at 30 ℃, the dissolved oxygen is controlled at 30%, the ventilation ratio is maintained at 1-2vvm, and stirring is associated with the dissolved oxygen until the yield is highest.
The genetically engineered bacterium is applied to epsilon-polylysine and hydrochloride production thereof.
Specifically, the preparation and detection of the correlation are as follows:
example 1.S.diastatochromogenes dapE-1 obtaining of the dapE Gene of the engineering Strain
According to the gene design primer sequence dap-F/dap-R, a single-enzyme homologous recombination strategy is adopted to construct a recombinant vector, ecoR I cleavage sites are added at two ends of the gene dapE, wherein EcoR I cleavage sites and 15 nucleotides identical to EcoR I upstream of the original vector pIMEP are added at the 5 'end of the upstream of the nucleotide sequence of the dapE gene to form an upstream homology arm, ecoR I cleavage sites and 15 nucleotides identical to EcoR I downstream of the original vector pIMEP are added at the 5' end of the downstream of the nucleotide sequence of the dapE gene to form a downstream homology arm, and the sequence table SEQ ID No.2 and SEQ ID No.3 are used as upstream and downstream primers, so that the total length 1089bp of the dapE gene in the original strain S.diasonochrogenes 6 and 7 is amplified by PCR, see SEQ ID No.1 of the sequence table.
Wherein the reaction system and reaction conditions of PCR: 2X phanta max buffer. Mu.L, dNTP mix (10 mM) 1. Mu.L, template (20 ng/ul) 1. Mu.L, upstream and downstream primers ((SEQ No.2, SEQ No. 3)) 2. Mu.L (10. Mu.M) each, DMSO 2. Mu.L, phanta max X Super-Fidelity DNAPolymerase. Mu.L, and make up ultrapure water to 50. Mu.L. PCR reaction conditions: pre-denaturation at 95 ℃ for 5min; denaturation at 95℃for 15s, annealing at 58℃for 15s, extension at 72℃for 80s, total 30 cycles, extension at 72℃for 5min, and termination of the reaction at 4℃to obtain the objective gene dapE. The electrophoretogram of the target gene dapE product amplified by PCR is shown in FIG. 1.
EXAMPLE 2 construction of recombinant plasmid pIMEP containing the dapE Gene
And (3) connecting the PCR amplified dapE gene fragment with the homology arm with linear plasmid pIMEP subjected to EcoR I single enzyme digestion and integrated with the erythromycin promoter ermE with a strong promoter by using a homologous recombination method to obtain a recombinant plasmid pIMEP. Wherein, the homologous recombination system is as follows: linearized vector pIMEP 125.72ng, insert dapE43.56ng,5 XCE II Buffer 4. Mu.L, exnase II 2. Mu.L, supplemented with ultra pure water to 20. Mu.L, homologous recombination conditions: the reaction was carried out at 37℃for 30min and was reduced to 4 ℃. A schematic diagram of the construction of the dapE recombinant plasmid is shown in FIG. 2.
Example 3 recombinant plasmid pIMEP:. DapE transformation of E.coli DH 5. Alpha
Adding the recombinant plasmid pIMEP into a centrifuge tube containing E.coli DH5 alpha competent cells which are melted in an ice bath, flicking the tube wall, uniformly mixing, and carrying out ice bath for 30min. Heat shock at 42 ℃ for 90s followed by an immediate ice bath for 5min (this process does not move). Under aseptic conditions, 900 mu L of LB culture medium is added into a centrifuge tube, and after being stirred and mixed uniformly, the mixture is subjected to shaking culture at 37 ℃ for 45min at 200 r/min. Centrifuge tube 12000r/min for 1min, remove 900. Mu.L supernatant, blow mix the remaining liquid with a pipette, and apply to LB solid plates containing 30. Mu.g/mL apramycin resistance. The LB plate is inversely cultured at 37 ℃ for overnight until single colony is clearly distinguished, meanwhile, colony PCR is carried out on the transformant obtained by screening and the plasmid is extracted by taking the sequence table SEQ ID No.4 and the sequence table SEQ ID No.5 as the upstream primer and the downstream primer, ecoRI single enzyme digestion verification is carried out, and the enzyme digestion verification result is shown in figure 3: the recombinant plasmid pIMEP-dapE was successfully transformed into transformants, and the verified E.coli DH 5. Alpha. Positive transformants were stored.
Example 4 obtaining of high yield engineering Strain
Single colonies of E.coli DH 5. Alpha. Positive transformants were picked up and cultured overnight in 5mL LB liquid medium (containing 30. Mu.g/mL apramycin) with shaking at 37℃220r/min, pIMEP:: dapE recombinant plasmid in E.coli DH 5. Alpha. Positive transformants was extracted according to the conventional method, the recombinant plasmid was chemically transformed into helper strain E.coli ET12567 (pUZ 8002), the transformants were plated on LB plates containing 20 ng/. Mu.L kanamycin, 30 ng/. Mu.L apramycin and 20 ng/. Mu.L chloramphenicol resistance, and cultured upside down at 37℃for 24h. E.coli positive transformants were selected as single colonies in 5mL of LB (containing three antibiotics at the same concentration as in the previous step), cultured overnight at 37℃with shaking at constant temperature, and then transferred to fresh 50mL of LB liquid medium containing three antibiotics at 1% transfer rate (antibiotic concentration as in the previous step),shaking culture at 37deg.C to OD at 180r/min 600 Between 0.4 and 0.6. 40mL of bacterial liquid was collected by centrifugation at 8000r/min for 5min, the bacterial cells were washed 2 times with fresh LB to remove residual antibiotics, resuspended in 1mL of LB and placed on ice for later use, yielding treated E.coli ET12567 (pUZ 8002) positive transformant cells. 10mL of TES buffer solution with pH of 8.0 is added to a plate of S.diastatocochromenes 6-7 strain with good spore growth, spores are scraped off by a sterile inoculating loop, poured into a 250mL triangular flask containing glass beads, oscillated at 30 ℃ for 2 hours at 180r/min to break spore chains, and then filtered by sterile absorbent cotton to remove hyphae and collect spore suspension. The spore suspension is heated in a water bath at 50deg.C for 10min, immediately cooled to room temperature, then 10mLM G culture medium is added, and shaking culture is carried out at 37deg.C for 2h at 180r/min to germinate spores, and S.diastatochromene 6# -7 germinated spores are collected by centrifugation at 5000r/min for 5min and resuspended for use.
Mixing treated E.coli ET12567 (pUZ 8002) positive transformant cells with germinated S.diastatocochromagene6# -7 spores in equal volume, and uniformly coating on a medium containing 5mM Mg 2+ Is on SFM medium. Culturing at 30deg.C in an inverted manner. After 14h of inversion culture, the flat plate is covered by sterile water containing 20mg/mL of nalidixic acid and 20mg/mL of apramycin, and after the flat plate is dried, the inversion culture is continued for 3-5 days, positive monoclonal zygotes are screened, and the high-yield engineering strain S.diastatochromogen dapE-1 is obtained.
Example 5 high yield engineering Strain verification
After the screened and obtained dapE gene overexpression strain is subjected to polylysine fermentation medium shake flask fermentation for 30 hours, genome is extracted, and a pair of verification primers are designed at about 100bp upstream and about 100bp downstream of the dapE gene on a pIMEP plasmid and at the tail of the dapE gene: the specific sequences are SEQ ID No.6 and SEQ ID No.7, respectively, and the result is shown in FIG. 4, in which the dapE gene is successfully incorporated into the genome of 6# -7, and the corresponding band is not obtained in the genome of control 6# -7.
PCR reaction system: 2 Xphantamax buffer 25. Mu.L, dNTP mix (10 mM) 1. Mu.L, template (20 ng/ul) 1. Mu.L, each of the upstream and downstream primers ((10. Mu.M)) 2. Mu.L, DMSO 2. Mu.L, phanta max x Super-Fidelity DNA Polymerase. Mu.L, and ultra-pure water to 50. Mu.L. PCR reaction conditions: pre-denaturation at 95 ℃ for 5min; denaturation at 95℃for 15s, annealing at 55℃for 15s, extension at 72℃for 80s, 30 cycles, extension at 72℃for 5min, and termination of the reaction at 4 ℃.
EXAMPLE 6 production of epsilon-polylysine by fermentation of highly productive engineering Strain S.diastatocochromene dapE-1
Inoculating high-yield engineering strain S.diastatocochromene-1 on a bennett culture plate, and culturing at 28 ℃ for about 7 days until spores are produced; the spores were then inoculated into 500mL shake flasks containing 100mL of glucose-containing M3G medium and fermented at 28℃for 30h at 180 r/min. Transferring to new 100mL M3G medium containing glucose with inoculation amount of 6% for fermentation until the yield is highest, to obtain fermentation broth containing epsilon-polylysine, wherein the result is shown in figure 5, the yield of high-yield engineering strain S.diastatocochromene dapE-1 epsilon-polylysine is increased by 20.1% compared with that of original strain S.diastatocochromene 6, the glucose conversion rate is increased by 26.0% compared with that of original strain, and the thallus production strength is increased by 43.5% compared with that of original strain.
Or inoculating high-yield engineering strain S.diastatocochromene-1 on a bennett culture plate, and culturing at 28deg.C for about 7 days until spores are produced; the spores were then inoculated into 500mL shake flasks containing 100mL of glucose-containing M3G medium and fermented at 28℃for 30h at 180 r/min. The cultured seed liquid is inoculated into a 5L fermentation tank with 3LM3G fermentation medium at an inoculum size of 10 percent, the initial pH value is 6.8, and the two-stage control is carried out: in the stage I, the pH is controlled at 6.0 so as to be beneficial to the proliferation of thalli; step II, when the glucose concentration in the fermentation liquor is reduced to 10g/L, naturally reducing the pH to 4.0, then automatically feeding ammonia water with the concentration of 12.5% to maintain the pH at about 4.0, and simultaneously feeding a mixed solution (800 g/L,80 g/L) of glucose and ammonium sulfate to control the glucose concentration to about 10g/L so as to be beneficial to the production of products; in the fermentation process, the temperature is controlled at 30 ℃, the dissolved oxygen is controlled at 30%, the ventilation ratio is maintained at 1-2vvm, and stirring is associated with the dissolved oxygen until the yield is highest. As shown in FIG. 6, after 216 hours of fed-batch fermentation in a 5L fermenter, the highest yield of the original strain S.diaastochromogenes 6# -7 epsilon-polylysine was found to be 25.11g/L, and the highest yield of the genetically engineered strain S.diaastochromogenes dapE-1 epsilon-polylysine was found to be 30.73g/L, and it is obvious that the yield of the genetically engineered strain S.diaastochromogenes dapE-1 epsilon-polylysine was increased by 22.4% compared with the yield of the original strain 6# -7, and the cell production strength was increased by 31.8% compared with the original strain.
EXAMPLE 7 construction and use of high yield engineering Strain S.diastatocochromene dapE-2
Construction of a highly productive engineering strain S.diastatocochromene dapE-2 overexpressing the Streptomyces succinyldiaminopimelate disuccinate gene of Streptomyces succinyldiaminopimelate (Streptomyces galiaeus) and its use in fermentative production of epsilon-polylysine, wherein the nucleotide sequence of the Streptomyces succinyldiaminopimelate disuccinate gene of Streptomyces galileo (Streptomyces galilaeus) is SEQ No.8 and SEQ No.8 has 83.9% identity with SEQ No. 1:
the gene of the succinyldiaminopimelate dissuccinylase dapE of the Streptomyces galileo (Streptomyces galilaeus) is directly synthesized according to the nucleotide sequence of SEQ No.8 and is integrated at the EcoR I restriction enzyme cleavage site of the plasmid pIMEP to obtain a recombinant plasmid pIMEP:: dapE.
Adding the recombinant plasmid pIMEP into a centrifuge tube containing E.coli DH5 alpha competent cells which are melted in an ice bath, flicking the tube wall, uniformly mixing, and carrying out ice bath for 30min. Heat shock at 42 ℃ for 90s followed by an immediate ice bath for 5min (this process does not move). Under aseptic conditions, 900 mu L of LB culture medium is added into a centrifuge tube, and after being stirred and mixed uniformly, the mixture is subjected to shaking culture at 37 ℃ for 45min at 200 r/min. Centrifuge tube 12000r/min for 1min, remove 900. Mu.L supernatant, blow mix the remaining liquid with a pipette, and apply to LB solid plates containing 50. Mu.g/mL apramycin resistance. And (3) inversely culturing the LB plate at 40 ℃ overnight until single bacterial colonies are clearly distinguished, simultaneously carrying out bacterial colony PCR (polymerase chain reaction) and plasmid extraction by taking a sequence table SEQ ID No.4 and a sequence table SEQ ID No.5 as upstream and downstream primers, carrying out EcoRI single enzyme digestion verification, and preserving the verified E.coli DH5 alpha positive transformants. The results are shown in FIG. 7, in which the recombinant plasmid pIMEP-dapE has been successfully transformed into a transformant.
Single colonies of the E.coli DH 5. Alpha. Positive transformants were cultured overnight in 5mL LB liquid medium (containing 50. Mu.g/mL apramycin) with shaking at 37℃220r/minThe pIMEP in E.coli DH 5. Alpha. Positive transformants was extracted according to the conventional method by dapE recombinant plasmid, the recombinant plasmid was transferred to helper strain E.coli ET12567 (pUZ 8002), the transformants were plated on LB plates containing 25 ng/. Mu.L kanamycin, 50 ng/. Mu.L apramycin and 25 ng/. Mu.L chloramphenicol resistance, and cultured upside down at 37℃for 24h. E.coli ET12567 (pUZ 8002) positive transformants were selected as single colonies in 5mL LB (containing three antibiotics at the same concentration as in the previous step), cultured overnight at 40℃with shaking at constant temperature, then transferred to fresh 50mL LB liquid medium containing three antibiotics at 1% transfer rate (antibiotic concentration as in the previous step), cultured at 180r/min at 40℃with shaking to OD 600 Between 0.4 and 0.6. 40mL of bacterial liquid was collected by centrifugation at 8000r/min for 5min, the bacterial cells were washed 3 times with fresh LB to remove residual antibiotics, resuspended in 1mL of LB and placed on ice for later use, yielding treated E.coli ET12567 (pUZ 8002) positive transformant cells. 10mL of TES buffer solution with pH of 8.0 is added to a plate of S.diastatocochromenes 6-7 strain with good spore growth, spores are scraped off by a sterile inoculating loop, poured into a 250mL triangular flask containing glass beads, oscillated at 30 ℃ for 2 hours at 180r/min to break spore chains, and then filtered by sterile absorbent cotton to remove hyphae and collect spore suspension. The spore suspension is heated in a water bath at 50deg.C for 15min, immediately cooled to room temperature, then 10mL of M3G culture medium is added, and shaking culture is carried out at 40deg.C for 3h to germinate spores, and S.diastatochromene 6# -7 germinated spores are collected by centrifugation at 5000r/min for 5min and resuspended for later use.
Mixing treated E.coli ET12567 (pUZ 8002) positive transformant cells with germinated S.diastatocochromagene6# -7 spores in equal volume, and uniformly coating on a medium containing 8mM Mg 2+ Is on SFM medium. Culturing at 30deg.C in an inverted manner. After 18h of inversion culture, the flat plate is covered by sterile water containing nalidixic acid with the concentration of 25mg/mL and apramycin with the concentration of 25mg/mL, and after the flat plate is dried, the inversion culture is continued for 3-5 days, positive monoclonal zygotes are screened, and the high-yield engineering strain S.diastatochromogen dapE-2 is obtained.
Inoculating high-yield engineering strain S.diastatocochromene-2 on a bennett culture plate, and culturing at 35 ℃ for about 7 days until spores are produced; the spores were then inoculated into 500mL shake flasks containing 100mL of glucose-containing M3G medium and fermented at 35℃for 33h at 180 r/min. The cultured seed liquid is inoculated into a 5L fermentation tank with 3LM3G fermentation medium at an inoculum size of 10 percent, the initial pH value is 6.8, and the two-stage control is carried out: in the stage I, the pH is controlled at 6.0 so as to be beneficial to the proliferation of thalli; step II, when the glucose concentration in the fermentation liquor is reduced to 10g/L, naturally reducing the pH to 4.0, then automatically feeding ammonia water with the concentration of 12.5% to maintain the pH at about 4.0, and simultaneously feeding a mixed solution (800 g/L,80 g/L) of glucose and ammonium sulfate to control the glucose concentration to about 10g/L so as to be beneficial to the production of products; in the fermentation process, the temperature is controlled at 30 ℃, the dissolved oxygen is controlled at 30%, the ventilation ratio is maintained at 1-2vvm, and stirring is associated with the dissolved oxygen until the yield is highest.
As shown in FIG. 8, the fermentation result of high yield engineering bacteria S.diaastochromogenes dapE-2 fed-batch in a 5L fermenter shows that the maximum yield of epsilon-polylysine of the genetic engineering strain Streptomyces diastatochromogenes dapE-2 is 31.47g/L, the maximum yield of the original strain S.diaastochromogenes 6-7 epsilon-polylysine is 25.11g/L, the yield of epsilon-polylysine of the genetic engineering strain S.diaastochromogenes dapE-2 is obviously improved by 25.3% compared with the yield of the original strain, and the glucose conversion rate and the thallus production strength are respectively improved by 4.2% and 44.7% compared with the original strain.
The related gene sequences used in the present invention may be as follows:
Seq ID No.1
succinyldiaminopimelate disuccinate dapE nucleotide sequence:
atggagcgct ccactcaccc ccgccttgac ctgtcgctgg acgccgccgc actgaccgcg 60
cagctcgtcg acttcccgtc cgagagcggc aacgagaagg acctcgccga cgccgtcgag 120
gaagccctgc gtgccctgcc gcacctgacc gtcgaccggt acggcaacaa cgtcgtcgcc 180
cgcacgcacc tgggccgcgc ggagcgggtg gtgctcgccg gacacctcga caccgtgccg 240
atcgcggaca acgtcccctc ccggctcgac gaggacggcg tcctgtgggg ctgcggcacc 300
tgcgacatga agtcgggggt cgccgtccag ctccggatgg ccgccaccgt ccccgccccc 360
aaccgcgacc tgaccttcgt cttctacgac aacgaagagg tcgccgcgca cctcaacggc 420
ctcggccggg tcgccgacgc ccaccccgac tggctcgcgg gcgacttcgc cgtcctcctg 480
gagccctccg acggccaggt ggagggcggc tgccagggca ccctccgggt cctgctgcgc 540
accagcgggg agcgcgcgca ctccgcacgc agctggatgg gcgccaacgc catccacgcc 600
gcggcccccc tcctggcgac gctcgccgcc tacgagccgc gccgcccggt gatcgacggc 660
ctggagtacc gcgagggcct caacgcggtc cgcatcgagg gcggcgtggc cggcaacgtc 720
gtcccggacg cctgcaccgt caccgtcaac ttccgctacg caccggaccg cacccccgaa 780
gaggcggtgg cccacgtccg cgaggtcttc gcggactgcc ccgtggacga gttcgtcatc 840
gacgaccact ccccgggggc gctgcccggg ctgtcccacc cggccgccca ggcgttcatg 900
acggccgtcg gcggcagcgc gaagcccaag ttcggctgga ccgacgtctc ccgcttcagc 960
gccctcggcg tcccggccgt caactacggc cccggtgagg cgctgctcgc ccacaagaag 1020
gacgagcggg tcgcgatcga ccgcatcgcg cactgcgagg agcggctgcg cgcctggctt 1080
accgcctga 1089
Seq ID No.2
dapE-F: namely: 5' -ATCGGATCCGGTACCGAATTCATGGAGCGCTCCACTCACC-3’ 40
Wherein the underline is EcoRI cleavage site; thickening fonts into upstream homology arms
Seq ID No.3
wherein the underline is EcoRI cleavage site; thickening fonts into downstream homology arms
Seq ID No.4
p-F: namely: 5'-TGTAAAACGACGGCCAGT-3' 18 and 5218
Seq ID No.5
p-R: namely: 5'-CAGGAAACAGCTATGAC-3' 17 and 5217
Seq ID No.6
vdapE-F: namely: 5'-TGTAAAACGACGGCCAGT-3' 18 and 5218
Seq ID No.7
vdapE-R: namely: 5'-TCAGGCGGTAAGCCAGGC-3' 18 and 5218
Seq ID No.8
Streptomyces succinyldiaminopimelate disuccinate desuccinate dapE nucleotide sequence of Streptomyces galilaeus:
atggccgaga ccccgcttga cctcacgctg gacgccgctc tgctcaccgc gcagctcgtc 60
gacttcccct ccgagagcgg cacggagaag ccgctcgcgg acgccgtcga gacggccctg 120
cgcacgctgc cgcacctcac ggtggaccgg cacggcaaca acgtgatcgc ccgcacccgc 180
ctgggccgtc ccgagcgggt ggtcctcgcc ggccacatcg acaccgtccc gatcgccggc 240
aacgtcccgt cccggctgga cgcggacggc gtcctgtggg gctgcggcac ctgcgacatg 300
aaggcgggcg tcgccgtcca gctccgcatc gccgccacgg tccccgcccc caaccgggac 360
ctgaccttcg tcttctacga caacgaagag gtcgccgccg acctcaacgg cctcaagcac 420
gtcgccgaga cccacccgga ctggctggag ggcgacttcg cggtcctcct ggagccctcc 480
gacggccagg tcgagggcgg ctgccagggc accctgcggg tcctgctgaa gaccaggggc 540
gagcgggccc actcggcgcg cagctggatg ggctccaacg cgatccacgc ggccgccccg 600
atcctggccc gcctcgccgc gtacgagccg cgccacccgg tgatcgacgg cctggagtac 660
cgcgagggcc tcaacgccgt cggcatcacc gggggagtgg ccggcaacgt catccccgac 720
gagtgcgtcg tgaccgtcaa cttccgctac gcgcccgacc gtacgcccga ggaggccatc 780
gcccacgtcc gtgaggtgtt cgccggctgc ggggtggagg agttcgtcat cgacgaccac 840
agcggggcgg ccctgcccgg actctcgcac cccgccgcgg cggccttcat cgaggccgtg 900
ggcggtaccc cgcagcccaa gtacggctgg accgacgtgt cccgcttctc ggcgctcggt 960
gtgccggccg tcaactacgg tcctggcaac ccgcacttgg cgcacaagcg ggacgagcgg 1020
gtggacaccg cgaagatcct ggcgggggag gagcgactgc gggcctggct gaccgcgtga 1080
Although embodiments of the present invention have been disclosed for illustrative purposes, those skilled in the art will appreciate that: various substitutions, changes and modifications are possible without departing from the spirit and scope of the invention and the appended claims, and therefore the scope of the invention is not limited to the disclosure of the embodiments.
Claims (10)
1. A genetically engineered bacterium for high-yield epsilon-polylysine and streptomyces hydrochloride thereof is characterized in that: the engineering bacteria are amylase streptomyces chromogenes dapE (StreptomycesdiastatochromogenesdapE), the amylase streptomyces chromogenes dapE is obtained by over-expressing succinyldiaminopimelate dissuccinylase gene dapE in diaminopimelate DAP in S.diastatocochromagenes 6# -7, and the nucleotide sequence of the over-expressed dapE gene has 83.9% or more of the same as that of SEQ ID No. 1.
2. The genetically engineered bacterium for high-yield epsilon-polylysine and streptomyces hydrochloride thereof according to claim 1, wherein the genetically engineered bacterium is characterized by: the deposit number of S.diastatocochromagene6# -7 is: cgmccno.22261, date of preservation: 2021, 4 months 30, address: beijing, chaoyang area, north Chen Xi Lu 1, 3, china academy of sciences microbiological institute, deposit unit: china general microbiological culture Collection center (China Committee for culture Collection).
3. The construction method of high-yield epsilon-polylysine and Streptomyces hydrochloride genetically engineered bacteria thereof according to claim 1 or 2, which is characterized by comprising the following steps: the method comprises the following steps:
(1) Over-expression gene dapE, wherein the nucleotide sequence of the gene dapE has 83.9% and above consistency with SEQ ID No. 1;
(2) Amplifying or directly synthesizing the dapE gene by a PCR technology;
(3) The over-expression plasmid used in the construction was plasmid pIMEP with the strong promoter erythromycin promoter ermE.
4. The construction method of the genetically engineered bacteria of high-yield epsilon-polylysine and streptomyces hydrochloride thereof according to claim 3, wherein the construction method is characterized in that: the method comprises the following steps:
(1) Extracting the genome of S.diastatocochromagenes 6# -7, using the genome as a template, and amplifying a target gene by adopting a PCR technology, wherein the target gene is succinyldiaminopimelate dissuccinylase gene dapE; or directly synthesizing the dapE nucleotide sequence with the same function of other streptomyces obtained according to NCBI retrieval;
(2) Inserting the target gene dapE obtained in the step (1) between enzyme cutting sites of a plasmid pIMEP integrated with a strong promoter erythromycin promoter ermE to obtain a recombinant plasmid pIMEP carrying the target gene, converting the recombinant plasmid pIMEP into escherichia coli DH5 alpha, and screening to obtain escherichia coli DH5 alpha positive transformants;
(3) Extracting recombinant plasmid pIMEP in E.coli DH5 alpha positive transformant of step (2), namely dapE, firstly transforming the extracted recombinant plasmid pIMEP into E.coli ET12567 (pUZ 8002), coating on LB plate containing 20-25 ng/. Mu.L kanamycin, 30-50 ng/. Mu.L apramycin and 20-25 ng/. Mu.L chloramphenicol, selecting E.coli ET12567 (pUZ 8002) positive transformant, culturing in LB liquid culture medium containing same concentration of three antibiotics of kanamycin, apramycin and chloramphenicol at constant temperature of 37-40 deg.C overnight, transferring into LB liquid culture medium containing same concentration of kanamycin, apramycin and chloramphenicol antibiotic, culturing at 180r/min at 37-40 deg.C until OD 600 Between 0.4 and 0.6, centrifuging to collect bacterial liquid, washing bacterial cells with fresh LB for 2-3 times to remove residual antibiotics, re-suspending in LB liquid medium, and placing on ice to obtain treated Escherichia coliET12567 (pUZ 8002) positive transformant cells;
(4) Adding TES buffer solution with pH=8.0 to the plate of S.diastatocochromagene6# -7 strain producing spore on bennett culture medium, scraping S.diastatocochromagene6# -7 spore, pouring into a container containing glass beads, breaking spore chain by shaking at 30deg.C and 180r/min, filtering to remove mycelium, collecting spore suspension, cooling to room temperature after heat shock in water bath, adding M3G culture medium, shaking culturing at 37-40deg.C for 2-3 hr to germinate spores, centrifuging at 5000r/min for 5min to collect S.diastatocochromagene6# -7 germinated spores, and re-suspending for use;
(5) Mixing positive transformant E.coli ET12567 (pUZ 8002) of step (3) and S.diastatocochromagene6# -7 germinated spores of step (4) in equal volume, and uniformly coating on a substrate containing 5-8mMMg 2+ After the SFM culture medium is subjected to inversion culture for 14-18h at 30 ℃, the flat plate is covered by sterile water containing nalidixic acid with the concentration of 20-25mg/mL and apramycin with the concentration of 20-25mg/mL, the flat plate is dried and then is subjected to inversion culture for 3-5 days, and positive monoclonal zygotes are screened to obtain the high-yield engineering bacteria.
5. The construction method of the genetically engineered bacteria of high-yield epsilon-polylysine and streptomyces hydrochloride thereof according to claim 4 is characterized in that: the construction steps of the step (2) for carrying the target gene recombinant plasmid pIMEP are as follows:
(a) Obtaining the target fragment gene: designing a primer sequence dapE-F/dapE-R according to a required gene, introducing EcoRI enzyme cutting sites at two ends of the gene, wherein 6 nucleotides are added at the upstream 5 'end and 6 nucleotides are added at the downstream 5' end of the nucleotide sequence to form a restriction enzyme EcoRI site, and amplifying the target gene dapE in streptomyces diastatochromogenes 6-7 by PCR; or directly synthesizing a Streptomyces galileo (Streptomyces galilaeus) gene dapE with the same function;
The target gene dapE sequence in the amplified amylase streptomyces chromogenes 6-7 is as follows: SEQ ID No.1;
primer dapE-F: SEQ ID No.2;
primer dapE-R: SEQ ID No.3;
the sequence of the Streptomyces galileo (Streptomyces galileus) gene dapE is: SEQ ID No.8;
(b) Construction of recombinant plasmids: the EcoRI single enzyme digestion plasmid pIMEP is used for carrying out the connection between the amplified target gene fragment and the single enzyme digestion plasmid pIMEP plasmid after the EcoRI single enzyme digestion, thus obtaining a connection product recombinant plasmid, transforming the recombinant plasmid into E.coli DH5 alpha competent cells, screening E.coli DH5 alpha positive transformants for preservation, thus obtaining the recombinant plasmid pIMEP carrying the target gene, namely dapE.
6. The construction method of the genetically engineered bacteria of high-yield epsilon-polylysine and streptomyces hydrochloride thereof according to claim 5 is characterized in that: the pIMEP plasmid is constructed by connecting an erythromycin promoter ermE in front of a polyclonal site on the basis of a pSET152 plasmid, and the plasmid is an escherichia coli-streptomyces shuttle plasmid and can be used for expressing genes in streptomyces;
the formula of the culture medium is as follows:
every 1LM3G medium composition was: (NH) 4 ) 2 SO 4 10g,KH 2 PO 4 1.36g,K 2 HPO 4 0.8g, yeast extract 5g, pH adjusted to 7.2 with ammonia, water was added to volume to 900mL, and 100mL10 Xglucose stock solution was added;
Every 1L of M3G medium containing glucose, the fermentation medium is short: when the M3G culture medium is used for fermentation, 100ml of 10 multiplied by glucose mother liquor is added to 900ml of M3G; 10 x glucose stock: 50g of glucose was weighed and 1ml of 500 XSO was added 4 ·7H 2 O and 1ml20 XMgSO 4 ·7H 2 O, sterilizing after the volume is fixed to 100ml by deionized water;
the composition of the bennett culture medium per 1L is: 10g of glucose, 2g of peptone, 1g of yeast powder, 1g of beef extract, 15-20g of agar, adding water to supplement 1L, and regulating pH to 7.7 with NaOH;
the composition of each 1LSFM medium was: 30g of soybean cake powder, 20g of mannitol and 15-20g of agar powder, adding water to supplement 1L, and adjusting pH to 7.2-7.4 by NaOH; wherein, the soybean cake powder is used after the following treatment: adding 800-900mL tap water, boiling for 30-60min, and filtering with gauze.
7. A method for improving the yield of epsilon-polylysine and hydrochloride thereof by using the genetically engineered bacterium as claimed in claim 1 or 2, which is characterized in that: the method realizes the improvement of the fermentation level of epsilon-polylysine through the fermentation of streptomyces diastatochromogenes dapE.
8. The method according to claim 7, wherein: the method comprises the following steps:
the adopted strain is a genetically engineered strain which is used for over-expressing succinyldiaminopimelate dissuccinylase gene dapE, namely amylase streptomyces chromogenes dapE, the genetically engineered strain is inoculated on a bennett culture medium plate and is cultured at 28-35 ℃ until black gray conidia are produced; then inoculating the spores into a shaking bottle of an M3G culture medium containing glucose, culturing for 30-33 hours at 28-35 ℃ and 180rpm/min, transferring the cultured seed culture solution into the M3G culture medium containing glucose for shaking bottle or fermentation tank fed-batch fermentation, and obtaining the epsilon-polylysine-containing fed-batch fermentation amino acid fermentation liquor.
9. The method according to claim 8, wherein: the feed fermentation comprises the following steps:
initial ph=6.8, control in two stages: in the stage I, the pH is controlled at 6.0 so as to be beneficial to the proliferation of thalli; step II, when the glucose concentration in the fermentation liquor is reduced to 10g/L, naturally reducing the pH to 4.0, then automatically feeding ammonia water with the mass concentration of 12.5% to maintain the pH to 4.0, and simultaneously feeding a mixed liquor of glucose and ammonium sulfate to control the glucose concentration to 10g/L; in the fermentation process, the temperature is controlled at 30 ℃, the dissolved oxygen is controlled at 30%, the ventilation ratio is maintained at 1-2vvm, and stirring is associated with the dissolved oxygen until the yield is highest.
10. The use of the genetically engineered bacterium of claim 1 or 2 in the production of epsilon-polylysine and its hydrochloride.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310029098.2A CN116179375A (en) | 2023-01-09 | 2023-01-09 | High-yield epsilon-polylysine and streptomyces hydrochloride genetically engineered bacterium as well as construction method and application thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310029098.2A CN116179375A (en) | 2023-01-09 | 2023-01-09 | High-yield epsilon-polylysine and streptomyces hydrochloride genetically engineered bacterium as well as construction method and application thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN116179375A true CN116179375A (en) | 2023-05-30 |
Family
ID=86447126
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310029098.2A Pending CN116179375A (en) | 2023-01-09 | 2023-01-09 | High-yield epsilon-polylysine and streptomyces hydrochloride genetically engineered bacterium as well as construction method and application thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116179375A (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996041871A1 (en) * | 1995-06-13 | 1996-12-27 | Ajinomoto Co., Inc. | Process for producing l-lysine by fermentation |
US20040092710A1 (en) * | 2000-05-04 | 2004-05-13 | Madhavan Nampoothiri K. | Nucleotide sequences coding for the cdsA gene |
CN108504617A (en) * | 2018-04-10 | 2018-09-07 | 江南大学 | A kind of Escherichia coli recombinant strain and its construction method of high-yield L-lysine |
US20210269842A1 (en) * | 2018-10-05 | 2021-09-02 | Ajinomoto Co., Inc. | Method for Producing Target Substance by Bacterial Fermentation |
-
2023
- 2023-01-09 CN CN202310029098.2A patent/CN116179375A/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996041871A1 (en) * | 1995-06-13 | 1996-12-27 | Ajinomoto Co., Inc. | Process for producing l-lysine by fermentation |
US20040092710A1 (en) * | 2000-05-04 | 2004-05-13 | Madhavan Nampoothiri K. | Nucleotide sequences coding for the cdsA gene |
CN108504617A (en) * | 2018-04-10 | 2018-09-07 | 江南大学 | A kind of Escherichia coli recombinant strain and its construction method of high-yield L-lysine |
US20210269842A1 (en) * | 2018-10-05 | 2021-09-02 | Ajinomoto Co., Inc. | Method for Producing Target Substance by Bacterial Fermentation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN111394288A (en) | Recombinant corynebacterium glutamicum, construction method thereof and method for producing tetrahydropyrimidine by using recombinant corynebacterium glutamicum | |
CN111607608B (en) | Gene engineering high-yield strain streptomyces diastatochromogenes, method for improving yield of epsilon-polylysine and application | |
CN111621454B (en) | Gene engineering high-yield strain streptomyces diastatochromogenes, production method and application of epsilon-polylysine | |
CN111471633B (en) | Gene engineering high-yield strain streptomyces diastatochromogenes and method for improving yield of epsilon-polylysine | |
CN112899210B (en) | Method for improving validamycin fermentation level by enhancing positive regulatory protein gene expression | |
CN113897301B (en) | Production method and application of genetically engineered high-yield strain streptomyces diastatochromogenes and epsilon-polylysine | |
US20210324391A1 (en) | Recombinant microorganism, preparation method therefor and application thereof in producing coenzyme q10 | |
CN116179375A (en) | High-yield epsilon-polylysine and streptomyces hydrochloride genetically engineered bacterium as well as construction method and application thereof | |
CN113801834B (en) | Gene engineering streptomyces diastatochromogenes for high yield of toyocamycin and construction method and application thereof | |
CN114231474B (en) | Method for constructing genetically engineered amylase streptomyces chromogenes and improving epsilon-polylysine yield and application | |
CN113549587B (en) | Gene engineering high-yield strain streptomyces diastatochromogenes and method for improving yield of epsilon-polylysine | |
CN109554321B (en) | Genetically engineered bacterium for high-yield lipopeptide and application thereof | |
CN101892228B (en) | Engineering bacteria with high tolerance to acrylamide and acrylonitrile for producing nitrile hydratase and application thereof | |
CN116042416A (en) | Multi-gene over-expression streptomycete engineering strain for high-yield epsilon-polylysine, method and application | |
CN116286575B (en) | Method for efficiently expressing raw starch alpha-amylase by using bacillus subtilis | |
CN116515648A (en) | Genetic engineering strain for high-yield epsilon-polylysine and hydrochloride thereof, construction method and application thereof | |
CN117363552B (en) | Streptomyces luteolin gene engineering strain for producing natamycin and construction method thereof | |
CN114806992B (en) | RSH over-expression genetic engineering amylase streptomyces chromogenes and method for improving fermentation yield of toyocamycin | |
CN115011537B (en) | Engineering bacterium for producing high optical purity L-lactic acid by double anaerobic promoters and preparation method and application thereof | |
CN113969258B (en) | Construction method of bacillus subtilis artificial strain for converting arabinose into Feng Yuan element | |
CN112481290B (en) | Method for improving citric acid fermentation production level based on morphological gene co-interference | |
CN117987340B (en) | Alhagi sparsifolia engineering bacteria for high yield of extracellular polysaccharide, and construction method and application thereof | |
CN116042682B (en) | Engineering bacterium for producing 2' -fucosyllactose, construction method and application thereof | |
CN116622606A (en) | Streptomyces albus genetic engineering strain for high-yield epsilon-polylysine, construction method and application thereof | |
WO2020113365A1 (en) | Genetically engineered bacterium producing high yield of lipopeptides and use thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |